Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 513 | 1,135 | 60,049 | 5,336 | 2,887 |
| Gross Profit | 513 | 1,135 | 60,049 | 5,336 | 2,887 |
| Operating Expenses | 72,416 | 68,126 | 84,012 | 55,499 | 46,981 |
| Operating Income | -71,903 | -66,991 | -23,963 | -50,163 | -44,094 |
| Interest Expense | 1 | -6 | 0 | 0 | -3,811 |
| Other Income | 4,297 | 5,035 | 5,089 | 5,144 | -7 |
| Pre-tax Income | -67,607 | -61,950 | -18,874 | -45,019 | -40,290 |
| Net Income Continuous | -67,607 | -61,950 | -18,874 | -45,019 | -40,290 |
| Net Income | $-67,607 | $-61,950 | $-18,874 | $-45,019 | $-40,290 |
| EPS Basic Total Ops | -0.82 | -0.76 | -0.20 | -0.55 | -0.56 |
| EPS Basic Continuous Ops | -0.82 | -0.76 | -0.19 | -0.55 | -0.56 |
| EPS Diluted Total Ops | -0.82 | -0.76 | -0.20 | -0.55 | -0.56 |
| EPS Diluted Continuous Ops | -0.82 | -0.76 | -0.19 | -0.55 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -0.82 | -0.76 | -0.23 | -0.55 | N/A |
| EBITDA(a) | $-72,363 | $-67,298 | $-24,600 | $-49,896 | $-43,334 |